Thymopeptide enteric-coated tablets and entecavir can be taken together. Thymopeptide enteric-coated tablets have the role of immunomodulatory function, can enhance the human body’s ability to resist radiation, enhance the body’s cellular immune function, is mainly used for chronic hepatitis B and a variety of primary or secondary T-cell defective diseases. And entecavir tablets can inhibit hepatitis B virus production, usually used for the treatment of chronic hepatitis B with active viral replication, persistent elevation of serum aminotransferases, and active liver tissues. Both medications are used to treat chronic hepatitis B, and there are generally no adverse effects when used in combination. It is important to note that both drugs should be taken under medical supervision. Do not self-medicate to avoid serious adverse effects.